《美股》美生產物價降溫增減息預期 甲骨文暴漲37%領跑 標普500、納指齊破頂
甲骨文(ORCL.US)AI雲業務高速增長,股價大升近40%,並帶動晶片股走強。同時,美國8月生產物價指數(PPI)意外下降,增強市場對聯儲局下周減息的信心。美股周三再度創下歷史新高。
標普500指數上升0.4%至新高,納指攀升0.5%亦破頂,不過,道指早段下跌約100點,跌幅0.2%。
個股方面,甲骨文披露上季來自亞馬遜、Google及微軟的多雲數據庫收入按年飆升15倍,主要受惠於AI伺服器需求急升,投資者忽略該公司第一財季低於預期的收益和盈利,股價更推高37%。晶片巨頭英偉達(NVDA.US)及AMD(AMD.US)股價分別升4%及2%,投資者再度湧入人工智能概念股,帶動整體科技板塊表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.